Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Leukemia
Interventions
BIOLOGICAL

recombinant 70-kD heat-shock protein

Trial Locations (1)

06030-1601

University of Connecticut Health Center, Farmington

All Listed Sponsors
lead

UConn Health

OTHER

NCT00030303 - Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter